Proteomics Intl Labs Ltd has released a press release.
Appendix 4C - December 2019 Quarterly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- CE Mark for PromarkerD Hub predictive software for DKD
- Partnership provides funding for cutting-edge facility
- Proteomics raises $3m in heavily oversubscribed Placement
- CE Mark for predictive test for diabetic kidney disease
- Appendix 4C - September 2019 Quarterly Report
Later from Proteomics International Laboratories
- Proteomics patents biomarkers for diagnosis of endometriosis
- Proteomics International expands study with US big pharma
- Proteomics expands diagnostics R&D - the Promarker Pipeline
- CE Mark for Proteomics PromarkerD Immunoassay Kit
- Appendix 4C and Quarterly Report - March 2020
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories